当前位置:循环首页>正文

[AHA2009]Ernesto Schiffrin教授谈ACEI、ARB在心血管疾病中的应用

作者:国际循环网   日期:2009/11/26 13:29:00

国际循环网版权所有,谢绝任何形式转载,侵犯版权者必予法律追究。

《国际循环》:我们知道,血管紧张素II参与多种心血管疾病,比如冠心病、心衰和高血压。那么其两种受体的具体作用是什么?它们对心血管病的作用是否有轻重之分?

International Circulation:  It is known that the actions of angiotensin II contribute to a variety of cardiovascular diseases such as coronary artery disease, heart failure and hypertension.  What are the roles of the two receptors, angiotensin II type I  (AT-1) receptor and angiotensin II type II (AT-2) receptor?  Are they equally responsible for those conditions or can we favor one over the other?

Ernesto Schiffrin:  Actually AT-1 receptor is the main mediator for the actions of angiotensin II and is the main receptor involved in the pathophysiology leading to blood pressure elevation, cardiac remodeling, participating in heart failure, and contributing to the progression of chronic kidney disease.  The AT-2 receptor is in fact abundant in fetal life and is later down regulated.  It appears to again be up regulated if there is an inflammatory response and may have vascular protective effects.  We have provided some evidence for that in some conditions.  They seem to have two opposing effects, one is pathophysiological, certainly plays a role in physiology, continuing to maintain blood pressure when people are salt depleted or dehydrated.  When renin-angiotensin system is inappropriately activated then the AT-1 receptor is the one that is mediating the pathophysiological effects and perhaps AT-2 receptors are somewhat vasculo-protective, although this remains slightly controversial.

[1]  [2]  [3]  [4]  下一页

版面编辑:李雅峰


E.SchiffrinARBACEI

分享到: 更多


设为首页 | 加入收藏 | 关于我们 | 联系方式 | 招贤纳士
声明:国际循环网( www.icirculation.com)对刊载的所有文章、视频、幻灯、音频等资源拥有全部版权。未经本站许可,不得转载。
京ICP备15014970号-5  互联网药品信息服务资格证书编号(京)-非经营性-2017-0063  京公网安备 11010502033353号  增值电信业务经营许可证:京ICP证150541号
国际循环 版权所有   © 2004-2024 www.icirculation.com All Rights Reserved
公司名称:北京美赞广告有限公司 公司地址:北京市朝阳区朝阳门北大街乙12号天辰大厦1座1409 电话:010-51295530